CONFLICT OF INTEREST
MP receives research funding from various organisations including the Governmental bodies such as the MRC, EU Commission and Health Education England. MP also received partnership funding for the following: MRC Clinical Pharmacology Training Scheme (co-funded by MRC and Roche, UCB, Eli Lilly and Novartis); a PhD studentship jointly funded by EPSRC and Astra Zeneca; and grant funding from Vistagen Therapeutics. MP also received unrestricted educational grant support for the UK Pharmacogenetics and Stratified Medicine Network from Bristol-Myers Squibb and UCB. MP held a joint grant from NIHR with MC Diagnostics for the development of a HLA panel. None of the funding MP received is related to the current paper.
The remaining authors declare no conflicts of interest.